Key facts
- Rhino (Medical Records Systems)’s last known valuation is $113.0M (Jan 2026).
- It has raised $42.4M; the latest was Later Stage VC ($11.3M) in Jan 2026.
- Notable investors include Mana Ventures, Gaingels, Endless Frontier Labs, Qiming Venture Partners USA, AlleyCorp — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Rhino (Medical Records Systems)
- ·The full record, as it builds
Funding rounds
No funding rounds for Rhino (Medical Records Systems) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Rhino (Medical Records Systems)
Developer of a federated learning and edge-computing platform designed to collaborate without sharing data or compromising data privacy. The company's platform distributes computing technologies, and artificial intelligence models can continuously improve by learning from each new dataset and applying those learnings to the next, without requiring risky data transfers, enabling businesses to accelerate the creation and training of models that work consistently across different patient populations.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2020
- Employees
- 68
- Website
- rhinofcp.com/
- Ownership
- Privately Held (backing)
Rhino (Medical Records Systems) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rhino (Medical Records Systems) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rhino (Medical Records Systems) in its N-PORT filings yet. We sweep new filings monthly.